The Vincristine Sulfate Injection, cataloged under National Stock Number 6505-01-227-1609, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Eli Lilly and Company. Government technical data includes 7 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-227-1609 |
| Primary Part Number | NDC00002-7199-09 |
| Item Name | Vincristine Sulfate Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Eli Lilly and Company |
| Status | ACTIVE |
| Primary Container Content Quantity | 2.000 MILLILITERS |
| Supplementary Features | ANTI-NEOPLASTIC (CHEMOTHERAPY) AGENT |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | SYRINGE |
| Protective Storage Feature | ANTINEOPLASTIC DRUG |
| Active Medicament Medicinal Strength | 1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER |
| Total Primary Container Quantity | 3 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00002-7199-09 PRIMARY | Eli Lilly and Company (USA) |
| Reference | Meaning |
|---|---|
| ONCOVIN | 5/1 Secondary reference Eli Lilly and Company |
NSN 6505-01-227-1609 is a Vincristine Sulfate Injection, manufactured by Eli Lilly and Company, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-227-1609 has 1 manufacturer part number on file: NDC00002-7199-09 (Eli Lilly and Company).
Key specifications for NDC00002-7199-09: Primary Container Content Quantity: 2.000 MILLILITERS; Supplementary Features: ANTI-NEOPLASTIC (CHEMOTHERAPY) AGENT; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: SYRINGE. 7 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.